Medthority
@medthority.bsky.social
Get closer to the conversations that matter in medicine, with our award-winning #MedEd platform. From podcast episodes to videos and articles, our channel showcases the latest resources on medthority.com #MedSky
For healthcare professionals only.
For healthcare professionals only.
Balancing thrombosis and bleeding risk isn't simple. Get closer to the conversations that matter with our NEW expert roundtable, chaired by @gbarnesmd.bsky.social. Watch now for practical takeaways on the latest trial data in #thrombosis care #MedSky #CardioSky #HaemSky
ow.ly/r2rk50XGYub
ow.ly/r2rk50XGYub
December 10, 2025 at 4:45 PM
Balancing thrombosis and bleeding risk isn't simple. Get closer to the conversations that matter with our NEW expert roundtable, chaired by @gbarnesmd.bsky.social. Watch now for practical takeaways on the latest trial data in #thrombosis care #MedSky #CardioSky #HaemSky
ow.ly/r2rk50XGYub
ow.ly/r2rk50XGYub
📰It's news-day Tuesday! Can a new non-invasive urine DNA detection panel accurately detect bladder cancer? Get the news you need to know with the latest trial data on Medthority #MedSky #MedicalNews #BladderCancer #OncSky
ow.ly/ZB1550XGc7B
ow.ly/ZB1550XGc7B
December 9, 2025 at 12:02 PM
📰It's news-day Tuesday! Can a new non-invasive urine DNA detection panel accurately detect bladder cancer? Get the news you need to know with the latest trial data on Medthority #MedSky #MedicalNews #BladderCancer #OncSky
ow.ly/ZB1550XGc7B
ow.ly/ZB1550XGc7B
How is our evolving understanding of HRR biology reshaping the way we define and treat mPC? Listen to Alicia Morgans and Alex Wyatt discuss the impact of HRR mutations on testing strategies and the importance of multidisciplinary collaboration #MedSky #ProstateCancer #MedEd
ow.ly/lyyn50XFFX4
ow.ly/lyyn50XFFX4
December 8, 2025 at 2:10 PM
How is our evolving understanding of HRR biology reshaping the way we define and treat mPC? Listen to Alicia Morgans and Alex Wyatt discuss the impact of HRR mutations on testing strategies and the importance of multidisciplinary collaboration #MedSky #ProstateCancer #MedEd
ow.ly/lyyn50XFFX4
ow.ly/lyyn50XFFX4
Short on time? Our visual summary highlights key insights from #EASL2025 on the AATD liver care journey, designed to fit into your busy schedule. Download now for the updates you need to know on detection, care pathways, and emerging therapies #MedSky #LiverSky
ow.ly/maZ850XCIrT
ow.ly/maZ850XCIrT
December 5, 2025 at 12:34 PM
Short on time? Our visual summary highlights key insights from #EASL2025 on the AATD liver care journey, designed to fit into your busy schedule. Download now for the updates you need to know on detection, care pathways, and emerging therapies #MedSky #LiverSky
ow.ly/maZ850XCIrT
ow.ly/maZ850XCIrT
Have your say! How can we improve our resources to meet the evolving needs of medical professionals in your field? If you've got a spare 5 minutes, let us know why you choose Medthority, and what we can do better! #MedSky #HCPSurvey #MedicalEducation #MedEd
ow.ly/uxaK50XBY4Z
ow.ly/uxaK50XBY4Z
December 4, 2025 at 4:34 PM
Have your say! How can we improve our resources to meet the evolving needs of medical professionals in your field? If you've got a spare 5 minutes, let us know why you choose Medthority, and what we can do better! #MedSky #HCPSurvey #MedicalEducation #MedEd
ow.ly/uxaK50XBY4Z
ow.ly/uxaK50XBY4Z
Tune in to hear @gbarnesmd.bsky.social and @bbikdeli.bsky.social present their round-up of this year's major advances in VTE and AF management. Stay ahead in thrombosis care with insights on recent trial data and the shift towards treatment personalization #MedSky #CardioSky
ow.ly/Lnm450XBnMr
ow.ly/Lnm450XBnMr
December 3, 2025 at 4:14 PM
Tune in to hear @gbarnesmd.bsky.social and @bbikdeli.bsky.social present their round-up of this year's major advances in VTE and AF management. Stay ahead in thrombosis care with insights on recent trial data and the shift towards treatment personalization #MedSky #CardioSky
ow.ly/Lnm450XBnMr
ow.ly/Lnm450XBnMr
How does #alopeciaareata present in skin of color patients, and what makes its features more nuanced? Get actionable insights with our on-demand webinar chaired by Antonella Tosti on severity assessment tools and management strategies #MedSky #DermSky #MedEd #HCPWebinar
ow.ly/qBrH50XAIb8
ow.ly/qBrH50XAIb8
December 2, 2025 at 3:18 PM
How does #alopeciaareata present in skin of color patients, and what makes its features more nuanced? Get actionable insights with our on-demand webinar chaired by Antonella Tosti on severity assessment tools and management strategies #MedSky #DermSky #MedEd #HCPWebinar
ow.ly/qBrH50XAIb8
ow.ly/qBrH50XAIb8
What clinical features differentiate #CIDP? Watch Eduardo Nobile-Orazio share practical tips to ensure accurate differentiation between various neurological disorders, the importance of early diagnosis, and current treatment options #MedSky #NeuroSky #MedEd
ow.ly/QCx550XA31Z
ow.ly/QCx550XA31Z
December 1, 2025 at 3:02 PM
What clinical features differentiate #CIDP? Watch Eduardo Nobile-Orazio share practical tips to ensure accurate differentiation between various neurological disorders, the importance of early diagnosis, and current treatment options #MedSky #NeuroSky #MedEd
ow.ly/QCx550XA31Z
ow.ly/QCx550XA31Z
How do you navigate the complexities of diagnosing #alopeciaareata across different racial and ethnic groups? Listen to Brittany Craiglow and Amy McMichael discuss clinical and trichoscopic features, common misdiagnoses, and the role of SALT scoring #MedSky #DermSky
ow.ly/k9Gw50Xz0oO
ow.ly/k9Gw50Xz0oO
November 28, 2025 at 11:57 AM
How do you navigate the complexities of diagnosing #alopeciaareata across different racial and ethnic groups? Listen to Brittany Craiglow and Amy McMichael discuss clinical and trichoscopic features, common misdiagnoses, and the role of SALT scoring #MedSky #DermSky
ow.ly/k9Gw50Xz0oO
ow.ly/k9Gw50Xz0oO
What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? Alicia Morgans shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedSky #OncSky #ProstateCancer #Movember
ow.ly/ap8W50XyGu2
ow.ly/ap8W50XyGu2
November 27, 2025 at 4:09 PM
What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? Alicia Morgans shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedSky #OncSky #ProstateCancer #Movember
ow.ly/ap8W50XyGu2
ow.ly/ap8W50XyGu2
What are the #NMIBC updates from #ESMO25 you need to know? @ashishkamatmd.bsky.social and Paolo Gontero unpack the latest insights from last month's event, including the impact of BCG therapy shortages and how AI-driven pathology is reshaping risk stratification #MedSky #OncSky
ow.ly/LPaL50Xy4ZJ
ow.ly/LPaL50Xy4ZJ
November 26, 2025 at 1:08 PM
What are the #NMIBC updates from #ESMO25 you need to know? @ashishkamatmd.bsky.social and Paolo Gontero unpack the latest insights from last month's event, including the impact of BCG therapy shortages and how AI-driven pathology is reshaping risk stratification #MedSky #OncSky
ow.ly/LPaL50Xy4ZJ
ow.ly/LPaL50Xy4ZJ
What role does surgery play in the management of desmoid tumors? Watch Maya Niethard share the surgeon's perspective and key considerations when deciding whether surgery should be recommended to a patient at #DGHO25 #MedSky #OncSky #Oncology
ow.ly/AhsY50XxBqq
ow.ly/AhsY50XxBqq
November 25, 2025 at 4:35 PM
What role does surgery play in the management of desmoid tumors? Watch Maya Niethard share the surgeon's perspective and key considerations when deciding whether surgery should be recommended to a patient at #DGHO25 #MedSky #OncSky #Oncology
ow.ly/AhsY50XxBqq
ow.ly/AhsY50XxBqq
Did you know Medthority only publishes independent #medicaleducation? We bring you trusted resources across a range of specialties, making the latest evidence and insights easy to access as part of your daily routine #MedSky #MedEd #IME
ow.ly/HO4B50XwYoS
ow.ly/HO4B50XwYoS
November 24, 2025 at 4:30 PM
Did you know Medthority only publishes independent #medicaleducation? We bring you trusted resources across a range of specialties, making the latest evidence and insights easy to access as part of your daily routine #MedSky #MedEd #IME
ow.ly/HO4B50XwYoS
ow.ly/HO4B50XwYoS
Get closer to the conversations that matter from #EANO2025 with our concise summary on NF1-PN care. From the current treatment landscape to the latest advances on the horizon, catch up with the updates you need to know on Medthority now #MedSky #OncSky #NeuroSky
ow.ly/FZJk50XuOQH
ow.ly/FZJk50XuOQH
November 21, 2025 at 9:26 AM
Get closer to the conversations that matter from #EANO2025 with our concise summary on NF1-PN care. From the current treatment landscape to the latest advances on the horizon, catch up with the updates you need to know on Medthority now #MedSky #OncSky #NeuroSky
ow.ly/FZJk50XuOQH
ow.ly/FZJk50XuOQH
What do you think about Medthority? Let us know what matters to you in #medicaleducation, and what we can do better! Share your views in just 5 minutes with our quick survey. Your feedback is hugely valuable to help us improve our resources #MedSky #MedEd
ow.ly/PFGv50XuOla
ow.ly/PFGv50XuOla
November 20, 2025 at 4:40 PM
What do you think about Medthority? Let us know what matters to you in #medicaleducation, and what we can do better! Share your views in just 5 minutes with our quick survey. Your feedback is hugely valuable to help us improve our resources #MedSky #MedEd
ow.ly/PFGv50XuOla
ow.ly/PFGv50XuOla
How can you help patients and caregivers navigate the impacts of an #NMIBC diagnosis? Host @ashishkamatmd.bsky.social talks to husband and wife Doug and Camille in the latest episode of Expert voices - Navigating NMIBC. Listen now for first-hand patient insights #MedSky #MedEd
ow.ly/3JlR50Xu1b6
ow.ly/3JlR50Xu1b6
November 19, 2025 at 12:45 PM
How can you help patients and caregivers navigate the impacts of an #NMIBC diagnosis? Host @ashishkamatmd.bsky.social talks to husband and wife Doug and Camille in the latest episode of Expert voices - Navigating NMIBC. Listen now for first-hand patient insights #MedSky #MedEd
ow.ly/3JlR50Xu1b6
ow.ly/3JlR50Xu1b6
Catch up with the latest trial data on HLH/MAS presented at #ACR25, including biomarker-driven breakthroughs and early diagnostic strategies, free and on demand with Medthority #MedSky #MedEd #RareDisease #Hematology #Rheumatology #RheumSky
ow.ly/pq7y50XsOPg
ow.ly/pq7y50XsOPg
November 17, 2025 at 2:04 PM
Catch up with the latest trial data on HLH/MAS presented at #ACR25, including biomarker-driven breakthroughs and early diagnostic strategies, free and on demand with Medthority #MedSky #MedEd #RareDisease #Hematology #Rheumatology #RheumSky
ow.ly/pq7y50XsOPg
ow.ly/pq7y50XsOPg
We're nearly halfway through #Movember! Head over to Medthority to get closer to the conversations that matter in men's health with our Prostate Cancer Nexus, designed to support your clinical decisions #MedSky #ProstateCancer #MensHealth #MedEd
ow.ly/CWTe50XrGsC
ow.ly/CWTe50XrGsC
November 14, 2025 at 1:18 PM
We're nearly halfway through #Movember! Head over to Medthority to get closer to the conversations that matter in men's health with our Prostate Cancer Nexus, designed to support your clinical decisions #MedSky #ProstateCancer #MensHealth #MedEd
ow.ly/CWTe50XrGsC
ow.ly/CWTe50XrGsC
Do you care for people with a rare disease? Navigate these complex conditions with the latest congress highlights and expert opinions on a range of diseases, from HLH/MAS to NF1 #MedSky #RareDisease #MedEd
ow.ly/Oc0Q50Xrf4X
ow.ly/Oc0Q50Xrf4X
November 13, 2025 at 5:11 PM
Do you care for people with a rare disease? Navigate these complex conditions with the latest congress highlights and expert opinions on a range of diseases, from HLH/MAS to NF1 #MedSky #RareDisease #MedEd
ow.ly/Oc0Q50Xrf4X
ow.ly/Oc0Q50Xrf4X
🫁 This #LungCancerAwarenessMonth, catch up with the latest trial data from #ESMO25 on non-small-cell lung cancer (NSCLC). From treatment guidance to "reassuring" trial outcomes, get the updates you need to know on Medthority #MedSky #LungCancer
ow.ly/fnwp50XqsyE
ow.ly/fnwp50XqsyE
November 12, 2025 at 1:02 PM
🫁 This #LungCancerAwarenessMonth, catch up with the latest trial data from #ESMO25 on non-small-cell lung cancer (NSCLC). From treatment guidance to "reassuring" trial outcomes, get the updates you need to know on Medthority #MedSky #LungCancer
ow.ly/fnwp50XqsyE
ow.ly/fnwp50XqsyE
With new treatment options and assessment tools emerging, make sure your #alopeciaareata (AA) patients are getting the best possible care with expert insights in our NEW podcast series, Alopecia Areata in Conversation #MedSky #DermSky
ow.ly/vv1F50Xq2pE
ow.ly/vv1F50Xq2pE
November 11, 2025 at 4:02 PM
With new treatment options and assessment tools emerging, make sure your #alopeciaareata (AA) patients are getting the best possible care with expert insights in our NEW podcast series, Alopecia Areata in Conversation #MedSky #DermSky
ow.ly/vv1F50Xq2pE
ow.ly/vv1F50Xq2pE
Did you know you can watch exclusive Medthority videos on YouTube? Head over to our channel for expert perspectives on a range of specialties, from congress highlights at #ESMO25 to insights on shared decision-making in atrial fibrillation #MedSky #MedEd
ow.ly/fult50Xn2wX
ow.ly/fult50Xn2wX
November 10, 2025 at 2:22 PM
Did you know you can watch exclusive Medthority videos on YouTube? Head over to our channel for expert perspectives on a range of specialties, from congress highlights at #ESMO25 to insights on shared decision-making in atrial fibrillation #MedSky #MedEd
ow.ly/fult50Xn2wX
ow.ly/fult50Xn2wX
What does Félix Guerrero-Ramos think of upcoming shifts in clinical practice when managing #NMIBC? Guerrero-Ramos discusses what he’d like to see in future guidelines, including biomarker selection and better patient classification, at #ESMO25 #MedSky #OncSky
ow.ly/pX2E50XooEi
ow.ly/pX2E50XooEi
November 7, 2025 at 2:48 PM
What does Félix Guerrero-Ramos think of upcoming shifts in clinical practice when managing #NMIBC? Guerrero-Ramos discusses what he’d like to see in future guidelines, including biomarker selection and better patient classification, at #ESMO25 #MedSky #OncSky
ow.ly/pX2E50XooEi
ow.ly/pX2E50XooEi
How is the NMIBC treatment landscape shifting? Listen to Ashish Kamat host expert discussions with Roger Li, Joshua Meeks, and Fred Witjes in the latest episodes of our new podcast series, for insights that fit into your busy schedule #MedSky #BladderCancer #MedicalPodcast
ow.ly/c9vI50XnW2P
ow.ly/c9vI50XnW2P
November 6, 2025 at 4:58 PM
How is the NMIBC treatment landscape shifting? Listen to Ashish Kamat host expert discussions with Roger Li, Joshua Meeks, and Fred Witjes in the latest episodes of our new podcast series, for insights that fit into your busy schedule #MedSky #BladderCancer #MedicalPodcast
ow.ly/c9vI50XnW2P
ow.ly/c9vI50XnW2P
Get closer to the conversations that are changing clinical practice with our key highlights from #ESMO25. From summaries of the latest trial data to expert interviews, catch up with insights on bladder, prostate, and lung cancer care #MedSky #OncSky
ow.ly/Ho3q50Xnaux
ow.ly/Ho3q50Xnaux
November 5, 2025 at 3:44 PM
Get closer to the conversations that are changing clinical practice with our key highlights from #ESMO25. From summaries of the latest trial data to expert interviews, catch up with insights on bladder, prostate, and lung cancer care #MedSky #OncSky
ow.ly/Ho3q50Xnaux
ow.ly/Ho3q50Xnaux